Related Experiment Video

Updated: Aug 24, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 17, 2014

[Severe cardiopathies of childhood. Diagnosis, early treatment and remote sequelae]

L Mattioli, G L Nicolosi, C Hoover

    Giornale Italiano Di Cardiologia
    |January 1, 1980
    PubMed

    Insights

    This study followed 43 infants with severe heart defects, finding a 63% long-term survival rate. Early diagnosis and surgical intervention were crucial for managing these pediatric cardiovascular anomalies.

    Area of Science:

    • Pediatric Cardiology
    • Congenital Heart Defects
    • Cardiovascular Surgery

    Context:

    • Presents long-term follow-up data for 43 infants treated for life-threatening cardiovascular anomalies.
    • Focuses on outcomes at the University of Kansas Medical Center.
    • Highlights the challenges in managing severe congenital heart disease in infants.

    Purpose:

    • To evaluate the long-term survival rates of infants with severe cardiovascular anomalies.
    • To assess the necessity and impact of surgical interventions.
    • To emphasize the importance of early diagnosis in this patient population.

    Summary:

    • Long-term follow-up of 43 infants with severe cardiovascular anomalies revealed a 63% survival rate.
    • Sixty-seven percent of cases required palliative or corrective surgery.
    • Early diagnosis and surgical management are critical for improving outcomes.

    Impact:

    • Underscores the significance of timely diagnosis and surgical treatment for infants with congenital heart defects.
    • Provides valuable data for clinicians managing pediatric cardiovascular anomalies.
    • Contributes to the understanding of long-term prognosis in this high-risk group.

    More Related Videos

    Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System07:34

    Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

    Published on: May 5, 2018

    Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest04:55

    Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest

    Published on: May 26, 2023

    Related Concept Videos

    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Cardiomyopathy VI: Nursing Management01:29

    Cardiomyopathy VI: Nursing Management

    Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...